---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-352679"
form_type: "8-K"
ticker: "IDXX"
cik: "0000874716"
company_name: "IDEXX LABORATORIES INC /DE"
filed_at: "2021-12-09T23:59:59+00:00"
generated_at: "2026-06-28T02:40:14.216361+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# IDEXX enters $1B revolving credit facility with extended maturity and lower rates

## Summary
- Fourth amended & restated credit agreement provides $1B unsecured revolver with $250M accordion feature.
- Maturity extended to December 9, 2026 (from 2020 agreement's 3-year term).
- Interest rate margins reduced; pricing (LIBOR + 0.875–1.375%) based on consolidated leverage ratio.
- New borrowers added: IDEXX Laboratories B.V. (Netherlands) and IDEXX Laboratories GmbH (Switzerland).
- Proceeds for general corporate purposes; commitment fee on unused portion ranges 0.075–0.250%.

## SEC filing metadata
- accession: 0001193125-21-352679
- form_type: 8-K
- ticker: IDXX
- cik: 0000874716
- company_name: IDEXX LABORATORIES INC /DE
- filed_at: 2021-12-09T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874716/000119312521352679/0001193125-21-352679-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874716/000119312521352679/d264618d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-352679
- JSON: https://secwatch.observer/filing/0001193125-21-352679.json
- Plain text: https://secwatch.observer/filing/0001193125-21-352679.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.